États-Unis · Presse financière · Investor's Business Daily

Merck Beats, But Can Shares Outplay The Cancer Vaccine News?

Publié par Investor's Business Daily · États-Unis il y a 1 h

Dow Jones component Merck hiked its 2026 outlook Thursday on the back of a solid third-quarter report that included a notable Keytruda beat. The post Merck Beats, But Can Shares…

Lire l'article complet sur Investor's Business Daily Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.investors.com)

Merck Beats, But Can Shares Outplay The Cancer Vaccine News?

À lire aussi

Oil Is Gushing Out of the Gulf. Why Are Prices Still Above $100 a Barrel?

Reddit’s AI Traffic Loss Still in Focus as Earnings Approach

Merck Beats, But Can Shares Outplay The Cancer Vaccine News?

Partager

À lire aussi

Oil Is Gushing Out of the Gulf. Why Are Prices Still Above $100 a Barrel?

Reddit’s AI Traffic Loss Still in Focus as Earnings Approach